Drugs / AdiaVita
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07622316 | Jun → Dec 2026 expected | autism | Greater Atlanta Integrative Pediatrics | Recruiting | No outcome recorded |
| Phase 1 | NCT07304440 | May 2026 → Jun 2028 expected | autism | Adia Med of Winter Park LLC | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdiaVita | “This clinical research study evaluates the safety and preliminary effects of AdiaVita (umbilical cord blood-derived stem cells and exosomes) combined with glutathione versus...” NCT07622316 ↗1“This 12-month study tests whether AdiaVita (umbilical cord blood-derived stem cells and exosomes) plus glutathione improves autism symptoms more than glutathione alone in...” NCT07304440 ↗ |
| Modality | Cell therapy | “umbilical cord blood-derived stem cells and exosomes” NCT07304440 ↗ |
| Route | Intravenous | “One group receives monthly IV AdiaVita plus IV glutathione for 3 months.” NCT07304440 ↗ |